Terapia com células-tronco & Pesquisa Clínica

Porto Vallarta, Mexico WhatsApp: +447778936902 , +33745637397, +34670491885 e-mail: [email protected] Plasmapheresis can be used to treat a variety of autoimmune disorders including: myasthenia gravis.Guillain-Barre syndrome.chronic inflammatory demyelinating polyneuropathy.Lambert-Eaton myasthenic syndrome opioid / álcool / drug addiction Plasmapheresis–  é a remoção, tratamento, and return or exchange of blood plasma or components thereof from Leia mais

Lista de terapias com células-tronco aprovadas pela FDA em 2022 ALOCORD (HPC, Sangue do cordão umbilical), Centro Médico Infantil Cardeal Glennon do SSM. “For use in unrelated donor hematopoietic progenitor cell transplantation procedures in conjunction with an appropriate preparative regimen for hematopoietic and immunologic reconstitution in patients with disorders affecting the hematopoietic system that Leia mais

Cell Therapy ProductsAlofiselTIGENIXAn allogeneic stem cell therapy to treat complex perianal fistulas in patients with Crohn’s disease. Recebeu autorização de comercialização da UE em março 2018. CartistemMEDIPOSTA cellular therapeutic agent containing allogeneic human umbilical cord blood-derived mesenchymal stem cells, indicado para o tratamento de defeitos da cartilagem do joelho, como cartilagem articular traumática, Leia mais

Scientists have removed HIV from human immune cells using a new gene-editing technique Using the much-touted CRISPR/Cas9 gene editing method, scientists have demonstrated how they can edit HIV out of human immune cell DNA, and in doing so, can prevent the reinfection of unedited cells too. If you haven’t heard Leia mais

GCP AUDITOR CERTIFICATE verified: Nicolas Stylianides Date of GCP AUDITOR certification:18.06.2016 GCP Auditor certificate #839023531449 The GCP AUDITOR database is maintained and operated by the NBScience. O acesso ao público em geral é concedido a fim de aumentar a disponibilidade de informações relacionadas ao mandato da NBScience. The content of the database Leia mais

Cord Blood TherapiesCLEVECORD (Sangue do cordão umbilical HPC)CLEVELAND CORD BLOOD CENTERApproved by the U.S. FDA in 2016 for use in unrelated donor hematopoietic progenitor cell transplantation procedures. HPC Cord BloodBLOODWORKSApproved by the U.S. FDA in 2016 for use in unrelated donor hematopoietic progenitor cell transplantation procedures. HPC Cord BloodMD ANDERSON CORD BLOOD Leia mais

Tissue-Engineered ProductsAurixNUO THERAPEUTICSA biodynamic hematogel composed of platelet-rich plasma gel prepared from a small sample of a patient’s own platelets and plasma as a catalyst for healing indicated for the treatment of wounds. Comercializado nos EUA. na seção 361 para o Plasma Rico em Plaquetas e abaixo 510(k) clearance as Leia mais

Cell-Based Immunotherapy ProductsAbecmaBLUEBIRD BIOA chimeric antigen receptor (CARRO) Terapia com células T para adultos com mieloma múltiplo recidivante ou refratário. Aprovado pela FDA dos EUA em março 2021. Aprovado pela Health Canada em maio 2021. Aprovado pela EMA em agosto 2021. Aprovado para uso no Japão em fevereiro 2022. APCedenAPAC BIOTECHAPCeden Leia mais

Stem Cells Laboratory in Belize ( projeto)   This work showed high efficiency of stem cells in the treatment of serious diseases: doenças autoimunes (glomerulonefrite), SE, MND etc. obliterating endartheritis critical ischemia of the upper and lower extremities diabetic foot diabetes mellitus type 1 e digite 2 leucemia (célula peluda) Leia mais

Stem Cells Laboratory in Ethiopia ( projeto) This work showed high efficiency of stem cells in the treatment of serious diseases: doenças autoimunes (glomerulonefrite), SE, MND etc. obliterating endartheritis critical ischemia of the upper and lower extremities diabetic foot diabetes mellitus type 1 e digite 2 leucemia (célula peluda) Cirrose Leia mais

Gene Therapy ProductsCollategeneANGESA gene therapy consisting of an intramuscular injection of plasmid (ADN) coding for Hepatocyte Growth Factor (HGF), intended to grow blood vessels, for the treatment of critical limb ischemia. Approved in Japan in February 2019. GendicineSHENZHEN SIBIONO GENETECHA recombinant adenovirus engineered to express wildtype-p53 (rAd-p53), designed to treat Leia mais

Pagamento pela certificação e treinamento do GCP : Para pagar pelo treinamento e certificação do GCP

e-mail: [email protected] Stem cells benefits. Rejuvenescimento (antienvelhecimento) stem cells therapy apply to distinct categories of patient: Dr.. Ivan ( e-mail: [email protected] ) Médico, Doutorado, doctor of the highest category Location: Endereço: Novi Beograd , Sérvia 11070 Biotechnology laboratory: Equipment and reagents for stem cells processing –Thermo Fisher (EUA) Biotechnology laboratory Department Leia mais

Обучение и сертификация GCP .

Actemra Adcetris Adempas Afinitor Aldurazyme Alimta Alprostadil Ambisome Ammonaps Aricept Arimidex Arzerra Atgam Atriance Atripla Atripla Aubagio Avastin Avonex Baraclude Bendamustin Bernb Bicalutamide Blincyto Bondronat Bridion Caelyx Calciumfolinat CAmpto Cancidas Caprelsa Cayston Cecenu Cellcept Cerezyme Cimzia Colistin Cometriq Conjugase Copaxone Copegus Cosentyx Cotellic Crizalk Curosurf Cyramza Cytotect Daclavir Dacogen Daklinza Leia mais

Biomedical engineers and medical researchers at UNSW Sydney have independently made discoveries about embryonic blood stem cell creation that could one day eliminate the need for blood stem cell donors. The achievements are part of a move in regenerative medicine towards the use of ‘induced pluripotent stem cells’ to treat Leia mais

    The 19th World Congress of Aesthetic Medicine of the UIME will be held in Cape Town, South Africa from 14th to 16th February 2013, with training courses on the 13th February 2013. This is the 1st time in history that this world congress is being held in an Leia mais

        WEBSITE advertising

BackgroundAnthracycline-induced cardiomyopathy (AIC) may be irreversible with a poor prognosis, disproportionately affecting women and young adults. Administration of allogeneic bone marrow–derived mesenchymal stromal cells (allo-MSCs) is a promising approach to heart failure (AF) tratamento. ObjectivesSENECA (Stem Cell Injection in Cancer Survivors) was a phase 1 study of allo-MSCs in AIC. Leia mais